text: Bristol-Myers Squibb Net Slumps Bristol-Myers Squibb (BMY:NYSE - news - research) reported a sharply lower profit in the third-quarter as generic competition continued to eat away at drug sales and the company ratcheted up spending on research and development of new drugs.